Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Phenmetrazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 known ✓ | P23975 | 6/20 | 0.81 |
| ▸ | SLC6A3 known ✓ | Q01959 | 5/20 | 0.81 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.81 |
| ▸ | HTR2B | P41595 | 1/20 | 0.81 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.60 |
| ▸ | HTR1A | P08908 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.37 |
| ▸ | TACR1 | P25103 | 4/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenmetrazine SCHEMBL15154744 | 0.90 | SLC6A2 (1.00) | SLC6A2SLC6A3ADRA1AHTR2BCHRNA7 | |
| Phenmetrazine SCHEMBL265002 | 0.90 | SLC6A2 (1.00) | SLC6A2SLC6A3ADRA1AHTR2BCHRNA7 | |
| Phenmetrazine SCHEMBL15159760 | 0.90 | SLC6A2 (1.00) | SLC6A2SLC6A3ADRA1AHTR2BCHRNA7 | |
| Phenmetrazine SCHEMBL33984 | 0.90 | SLC6A2 (1.00) | SLC6A2SLC6A3ADRA1AHTR2BCHRNA7 | |
| Phenmetrazine SCHEMBL15159761 | 0.90 | SLC6A2 (1.00) | SLC6A2SLC6A3ADRA1AHTR2BCHRNA7 | |
| Phenmetrazine SCHEMBL8094204 | 0.90 | SLC6A2 (1.00) | SLC6A2SLC6A3ADRA1AHTR2BCHRNA7 | |
| Phenmetrazine SCHEMBL22462307 | 0.89 | SLC6A2 (0.96) | SLC6A2SLC6A3ADRA1AHTR2BCHRNA7 | |
| Phenmetrazine SCHEMBL121536 | 0.89 | SLC6A2 (0.96) | SLC6A2SLC6A3ADRA1AHTR2BCHRNA7 | |
| Phenmetrazine SCHEMBL28570473 | 0.84 | SLC6A2 (0.74) | SLC6A2SLC6A3ADRA1AHTR2BCHRNA7 | |
| Phenmetrazine SCHEMBL4392164 | 0.82 | SLC6A2 (0.72) | SLC6A2SLC6A3ADRA1AHTR2BCHRNA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010080449-A1 | BLOW-MOLDED THIN-WALLED DRUG DELIVERY CAPSULES | ADDS PHARMACEUTICALS LLC (US) | 2010-07-15 | — | — | WO | disclosed |
| US-20100158997-A1 | BLOW-MOLDED THIN-WALLED DRUG DELIVERY CAPSULES | ADDS PHARMACEUTICALS LLC | 2010-06-24 | — | — | US | disclosed |
| US-6719751-B2 | Osmotic dosage form composed of an extruded polymer tube form | DURECT CORPORATION | 2004-04-13 | — | — | US | disclosed |
| EP-1057478-B1 | Thermoplastic polymer membranes | ALZA CORP (US) | 2003-07-09 | — | — | EP | disclosed |
| US-20030055408-A1 | Osmotic dosage form composed of an extruded polymer tube form | DURECT CORPORATION | 2003-03-20 | — | — | US | disclosed |
| US-6491683-B1 | Osmotic dosage form composed of an extruded polymer tube form | ALZA CORPORATION | 2002-12-10 | — | — | US | disclosed |
| EP-0782440-B1 | INJECTION-MOLDED DOSAGE FORM | ALZA CORP (US) | 2001-07-25 | — | — | EP | disclosed |
| EP-1057478-A2 | Thermoplastic polymer membranes | ALZA CORPORATION (US) | 2000-12-06 | — | — | EP | disclosed |
| US-6153678-A | Injection-moldable composition and article of manufacture comprising same | ALZA CORPORATION (US) | 2000-11-28 | — | — | US | disclosed |
| WO-1999018159-A1 | INJECTION-MOLDABLE COMPOSITION AND ARTICLE OF MANUFACTURE COMPRISING SAME | ALZA CORPORATION (US) | 1999-04-15 | — | — | WO | disclosed |
| US-5830502-A | SOLVENT-FREE HOUSING | ALZA CORPORATION (US) | 1998-11-03 | — | — | US | disclosed |
| EP-0782440-A1 | INJECTION-MOLDED DOSAGE FORM | ALZA CORPORATION (US) | 1997-07-09 | — | — | EP | disclosed |
| US-5614578-A | Injection-molded dosage form | ALZA CORPORATION (US) | 1997-03-25 | — | — | US | disclosed |
| WO-1996013248-A1 | INJECTION-MOLDED DOSAGE FORM | ALZA CORPORATION (US) | 1996-05-09 | — | — | WO | disclosed |